SGLT2 Inhibitors

Type: Oral medications for Type 2 Diabetes Action: Increase glucose excretion in urine by blocking SGLT2 protein in kidneys

Benefits: Weight loss, blood pressure reduction

Risk: Risk of urinary infections, rare risk of diabetic ketoacidosis

Examples: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin